Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Non-alcoholic Fatty Liver Disease
|
222 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.070 | 1.000 | 7 | 2003 | 2016 | ||||
Parkinson Disease
|
990 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.070 | 0.571 | 7 | 2002 | 2016 | ||||
Breast Carcinoma
|
2793 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.060 | 1.000 | 6 | 2006 | 2015 | ||||
Childhood Acute Lymphoblastic Leukemia
|
261 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.060 | 1.000 | 6 | 2002 | 2014 | ||||
Coronary Arteriosclerosis
|
440 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.060 | 1.000 | 6 | 2001 | 2009 | ||||
Fatty Liver Disease
|
81 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.060 | 1.000 | 6 | 1998 | 2012 | ||||
Malignant neoplasm of breast
|
3417 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.060 | 1.000 | 6 | 2006 | 2015 | ||||
Cooley's anemia
|
19 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.050 | 1.000 | 5 | 2000 | 2019 | ||||
MYELODYSPLASTIC SYNDROME
|
95 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.050 | 1.000 | 5 | 2003 | 2015 | ||||
Alcoholic Liver Diseases
|
20 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.040 | 1.000 | 4 | 1999 | 2003 | ||||
Arthropathy
|
10 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.040 | 1.000 | 4 | 2006 | 2014 | ||||
Celiac Disease
|
263 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.040 | 1.000 | 4 | 2002 | 2018 | ||||
Hepatitis B
|
519 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.040 | 1.000 | 4 | 2001 | 2011 | ||||
HFE-Associated Hereditary Hemochromatosis
|
3 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.040 | 1.000 | 4 | 2002 | 2014 | ||||
Mean Corpuscular Volume (result)
|
549 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.800 | 1.000 | 4 | 2009 | 2012 | ||||
Acute lymphocytic leukemia
|
222 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2002 | 2013 | ||||
Anemia, Hemolytic
|
31 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 1998 | 2009 | ||||
Arteriosclerosis
|
267 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2000 | 2008 | ||||
Atherosclerosis
|
281 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2000 | 2008 | ||||
beta Thalassemia
|
103 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2005 | 2017 | ||||
beta^+^ Thalassemia
|
44 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2005 | 2017 | ||||
Cardiovascular Diseases
|
711 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2001 | 2008 | ||||
Cerebrovascular accident
|
591 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2002 | 2014 | ||||
Childhood Leukemia
|
140 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2002 | 2006 | ||||
Degenerative polyarthritis
|
247 | 0.435 | 0.880 | 6 | 26092913 | missense variant | G/A | snv | 3.3E-02 | 3.8E-02 | 0.030 | 1.000 | 3 | 2003 | 2018 |